Madhu P. Menon
No Rating Available
(Learn About Our Rating System)

Madhu P. Menon, MD, PhD

Languages spoken: English

  • Dr. Menon is the Section Chief of Hematopathology at ARUP Laboratories and an Associate Professor of Pathology at the University of Utah School of Medicine.

    Specialties

    • Pathology, Clinical

    Board Certification

    American Board of Pathology (Anatomic & Clinical)
    American Board of Pathology (Sub: Hematology)

  • Dr. Menon is the Section Chief of Hematopathology at ARUP Laboratories and an Associate Professor of Pathology at the University of Utah School of Medicine.

    Board Certification and Academic Information

    Academic Departments Pathology -Primary
    Board Certification
    American Board of Pathology (Anatomic & Clinical)
    American Board of Pathology (Sub: Hematology)

    Education history

    Post Graduate Training Hematopathology - Johns Hopkins University Hospital Visiting Fellow
    Hematopathology - Laboratory of Pathology, National Cancer Institute, National Institutes of Health Clinical Fellow
    Post Graduate Training Hematopathology - George Washington University Hospital Visiting Fellow
    Anatomic & Clinical Pathology - University of Massachusetts Medical School Chief Resident
    Fellowship Hematopathology - Laboratory of Pathology, National Institutes of Health Visiting Fellow
    Hematopathology - Massachusetts General Hospital Clinical Observership
    Residency Anatomic & Clinical Pathology - University of Massachusetts Medical School Resident
    Maine Medical Center Research Institute Postdoctoral Fellow
    Doctoral Training Molecular Medicine - Huck Institute of Life Sciences, Pennsylvania State University Ph.D.
    Medicine - Baroda Medical College, Maharaja Sayajirao University M.B.B.S.

    Selected Publications

    Journal Article

    1. Anderson J, Putnam E, Liu W, Menon MP (2022). Discovery of G6PD deficiency in a patient with DUSP22-rearranged ALK-negative anaplastic large cell lymphoma in leukemic phase. Int J Lab Hematol, 44(1), 67-68.
    2. Van Slambrouck C, Huh J, Suh C, Song JY, Menon MP, Sohani AR, Duffield AS, Goldberg RC, Dama P, Kiyotani K, Godfrey J, Fitzpatrick C, Kline J, Smith SM, Jaffe ES, Hartmann S, Venkataraman G (2019). Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities. Mod Pathol, 33(5), 834-845. (Read full article)
    3. Fatima S, Dsa H, Chaffins ML, Menon M, Friedman BJ (2020). An Elderly Male with a Chronic Rash on the Right Foot. Indian J Dermatol, 65(3), 222-224. (Read full article)
    4. Kezlarian B, Alhyari M, Venkataraman G, Karner K, Inamdar KV, Menon MP (2017). GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities. Appl Immunohistochem Mol Morphol, 27(3), 180-184. (Read full article)
    5. Datta L, Menon MP (2017). Plasmacytoid lymphocytes: a clue to dengue diagnosis. Blood, 129(15), 2202. (Read full article)
    6. Alikhan M, Song JY, Sohani AR, Moroch J, Plonquet A, Duffield AS, Borowitz MJ, Jiang L, Bueso-Ramos C, Inamdar K, Menon MP, Gurbuxani S, Chan E, Smith SM, Nicolae A, Jaffe ES, Gaulard P, Venkataraman G (2016). Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic. Mod Pathol, 29(10), 1173-82. (Read full article)
    7. Menon MP, Nicolae A, Meeker H, Raffeld M, Xi L, Jegalian AG, Miller DC, Pittaluga S, Jaffe ES (2015). Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis. Am J Surg Pathol, 39(12), 1719-1729. (Read full article)
    8. Gulati R, Menon MP (2015). Indicators of true intracerebral hemorrhage: hematoidin, siderophage, and erythrophage. Blood, 125(23), 3664. (Read full article)
    9. Vidholia A, Menon MP (2015). "Cup-like" blasts in acute myeloid leukemia with FLT3 and NPM1 mutations. Blood, 125(5), 889. (Read full article)
    10. Gulati R, Alkhatib Y, Donthireddy V, Felicella MM, Menon MP, Inamdar KV (2015). Isolated Ocular Manifestation of Relapsed Chronic Myelogenous Leukemia Presenting as Myeloid Blast Crisis in a Patient on Imatinib Therapy: A Case Report and Review of the Literature. Case Rep Pathol, 2015, 380451. (Read full article)
    11. Menon MP, Hutchinson L, Garver J, Jaffe ES, Woda BA (2013). Transformation of follicular lymphoma to Epstein-Barr virus-related Hodgkin-like lymphoma. J Clin Oncol, 31(5), e53-6. (Read full article)
    12. Menon MP, Pittaluga S, Jaffe ES (2012). The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification. Cancer J, 18(5), 411-20. (Read full article)
    13. Tang G, Wang SA, Menon M, Dresser K, Woda BA, Hao S (2011). High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes. Leuk Res, 35(6), 766-70. (Read full article)
    14. Menon MP, Khan A (2009). Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications. J Clin Pathol, 62(11), 978-85. (Read full article)
    15. Bogacheva O, Bogachev O, Menon M, Dev A, Houde E, Valoret EI, Prosser HM, Creasy CL, Pickering SJ, Grau E, Rance K, Livi GP, Karur V, Erickson-Miller CL, Wojchowski DM (2008). DYRK3 dual-specificity kinase attenuates erythropoiesis during anemia. J Biol Chem, 283(52), 36665-75. (Read full article)
    16. Fang J, Menon M, Zhang D, Torbett B, Oxburgh L, Tschan M, Houde E, Wojchowski DM (2008). Attenuation of EPO-dependent erythroblast formation by death-associated protein kinase-2. Blood, 112(3), 886-90. (Read full article)
    17. Sathyanarayana P, Dev A, Fang J, Houde E, Bogacheva O, Bogachev O, Menon M, Browne S, Pradeep A, Emerson C, Wojchowski DM (2008). EPO receptor circuits for primary erythroblast survival. Blood, 111(11), 5390-9. (Read full article)
    18. Fang J, Menon M, Kapelle W, Bogacheva O, Bogachev O, Houde E, Browne S, Sathyanarayana P, Wojchowski DM (2007). EPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblasts. Blood, 110(7), 2361-70. (Read full article)
    19. Sathyanarayana P, Menon MP, Bogacheva O, Bogachev O, Niss K, Kapelle WS, Houde E, Fang J, Wojchowski DM (2007). Erythropoietin modulation of podocalyxin and a proposed erythroblast niche. Blood, 110(2), 509-18. (Read full article)
    20. Menon MP, Fang J, Wojchowski DM (2005). Core erythropoietin receptor signals for late erythroblast development. Blood, 107(7), 2662-72. (Read full article)
    21. Menon MP, Karur V, Bogacheva O, Bogachev O, Cuetara B, Wojchowski DM (2005). Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis. •    Article accompanied by editorial commentary. J Clin Invest. 2006 Mar;116(3):626-8.Gregory Longmore. A unique role for Stat5 in recovery from acute anemia.  •    Article discussed in BioWOrld Today. Anette Breindl (Science editor). I need phosphorylated 343, STAT! Study offers insight in Blood cell formation under stress. March 20, 2006.  . J Clin Invest, 116(3), 683-94. (Read full article)
    22. Wojchowski DM, Menon MP, Sathyanarayana P, Fang J, Karur V, Houde E, Kapelle W, Bogachev O (2006). Erythropoietin-dependent erythropoiesis: New insights and questions. Blood Cells Mol Dis, 36(2), 232-8. (Read full article)
    23. Li K, Menon MP, Karur VG, Hegde S, Wojchowski DM (2003). Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells. Blood, 102(9), 3147-53. (Read full article)

    Case Report

    1. Vaddepally RK, Hejab A, Dabak V, Menon M (2019). A rare case of follicular lymphoma transformed to a high-grade B-cell lymphoma in orbit. Clin Case Rep, 7(5), 1053-1056. (Read full article)

    Letter

    1. Menon MP, Evbuomwan MO, Rosai J, Jaffe ES, Pittaluga S (2013). A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease? [Letter to the editor]. Histopathology, 64(3), 455-9. (Read full article)